Therapy of obstructive bronchial diseases: the physicochemical approach.
D000468:Alkalies / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001980:Bronchi / Q000378:metabolism / Q000502:physiology; D001982:Bronchial Diseases / Q000175:diagnosis / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004247:DNA; D005081:Exercise Therapy; D005340:Fibrinogen; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006813:Humidity; D006863:Hydrogen-Ion Concentration; D006867:Hydrolases; D007454:Iodides / Q000627:therapeutic use; D007477:Ions; D007509:Irritants / Q000494:pharmacology; D008173:Lung Diseases, Obstructive / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D008954:Models, Biological; D008956:Models, Chemical; D009077:Mucins; D009093:Mucus / Q000378:metabolism / Q000502:physiology; D011108:Polymers; D013183:Sputum; D014132:Trachea / Q000378:metabolism / Q000502:physiology; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014783:Viscosity; D005719:gamma-Globulins / Q000627:therapeutic use
D000468:Alkalies; D000890:Anti-Infective Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D007454:Iodides; D007477:Ions; D007509:Irritants; D009077:Mucins; D011108:Polymers; D014149:Tranquilizing Agents; D005719:gamma-Globulins; D005340:Fibrinogen; D004247:DNA; D006867:Hydrolases